Hip pain
Also known as: Pain, Ache, Hurt, Cramp
Methodology & AI Transparency ⓘ
Hip pain Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Under Osteoarthritis, Gout & Joint Pain diagnostic criteria (M25.559), workup for Hip pain (also termed Pain or Ache) integrates synovial fluid crystal/cell in Hip pain (M25.559: analysis when effused) with evidence-graded therapy tailored to hs-CRP & Erythrocyte in Hip pain (M25.559: Sedimentation Rate) response.
- 2 Real-world patient consensus: Synonyms for Hip pain (M25.559): Pain, Ache, Hurt (Arthritis & Joints).
- 3 Typical cash cost range: Clinicians assessing Hip pain focus on low-grade synovial metalloproteinase in Hip pain (M25.559: release) and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Hip pain: hs-CRP & Erythrocyte in Hip pain (M25.559: Sedimentation Rate) (hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M25.559)) and Weight-Bearing Joint Radiograph [Hip pain M25.559].
Ask our AI Specialists anything about Hip pain
What Is Hip pain?
Under Osteoarthritis, Gout & Joint Pain diagnostic criteria (M25.559), workup for Hip pain (also termed Pain or Ache) integrates synovial fluid crystal/cell in Hip pain (M25.559: analysis when effused) with evidence-graded therapy tailored to hs-CRP & Erythrocyte in Hip pain (M25.559: Sedimentation Rate) response.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Hip pain (ICD-10 M25.559) is driven by low-grade synovial metalloproteinase in Hip pain (M25.559: release); specialists in Osteoarthritis, Gout & Joint Pain monitor Weight-Bearing Joint Radiograph [Hip pain M25.559] to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Hip pain (M25.559): activity-related deep aching in Hip pain (M25.559: joint pain in)
- • Secondary Hip pain clinical sign: brief morning joint in Hip pain (M25.559: stiffness)
- • Symptom flares in Hip pain correlating with hs-CRP & Erythrocyte in Hip pain (M25.559: Sedimentation Rate) deviation outside hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M25.559)
- • Functional arthritis & joints impact requiring synovial fluid crystal/cell in Hip pain (M25.559: analysis when effused) evaluation (M25.559)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Hip pain Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | M25.559 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Osteoarthritis, Gout & Joint Pain | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: hs-CRP & Erythrocyte in Hip pain (M25.559: Sedimentation Rate) | hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M25.559) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Weight-Bearing Joint Radiograph [Hip pain M25.559] | Preserved joint-space width (M25.559) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Uric Acid in Hip pain (M25.559: (Gout Target)) | < 6.0 mg/dL (< 5.0 mg/dL with tophi) (M25.559) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Hip pain
Treatment selection for Hip pain depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Hip pain)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Postoperative Pain Treatment After Pancreatic: What a 1,468-Participant Study Found The available evidence was insufficient to establish the superiority of any single pain-relieving strategy after major pancreatic surgery. European journal of pain (London, England) • 2026-11-15 • Meta-Analysis | N = 1,468 | 99/100 | PMID 42944586 ↗ |
| New Insights on Pain Reduction in Linzagolix-Treated Patients With Uterine Fibroids: A Secondary: What a 1,012-Participant Study Found This analysis showed that reductions in pain were significantly mediated by reductions in HMB (all doses) and FV (200 mg alone) in linzagolix-treated women with UFs. BJOG : an international journal of obstetrics and gynaecology • 2025-08-15 • Phase III Randomized Trial | N = 1,012 | 96/100 | PMID 40326221 ↗ |
| New Insights on Exercise Type and Duration on Pain, Function, and Quality of Life in Patients: What a 3,808-Participant Study Found J Orthop Sports Phys Ther 2026;56(11):724-734. The Journal of orthopaedic and sports physical therapy • 2026-11-15 • Meta-Analysis | N = 3,808 | 94/100 | PMID 42966901 ↗ |
| New Insights on Efficacy of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute: What a 344-Participant Study Found This pooled analysis reinforces the efficacy profile of CTC versus tramadol and, given that CTC permits lower daily tramadol dosing and thereby reduces unnecessary opioid use, this highlights its improved benefit/risk profile... Drugs in R&D • 2024-06-15 • Phase III Randomized Trial | N = 344 | 93/100 | PMID 38874739 ↗ |
| New Insights on Clobetasol Propionate Ophthalmic Suspension to Treat Ocular Inflammation and Pain: What a 366-Participant Study Found CPN 0.05% twice daily for 14 days was safe and rapidly improved inflammation, OP, and visual acuity after cataract surgery. Ophthalmology • 2026-08-15 • Phase III Randomized Trial | N = 366 | 93/100 | PMID 42097332 ↗ |
Hip pain Patient Community & “People Like Me” Threads
Filter Hip pain community threads and patient logs by age, biological sex, dosage, and treatment duration.